4 results for author:"Chaffee S.C." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors. Buchanan J.L., Newcomb J.R., Carney D.P., Chaffee S.C., Chai L., Cupples R., Epstein L.F., Gallant P., Gu Y., Harmange J.C. et al. Bioorg. Med. Chem. Lett. 21:2394-2399(2011) · UniProtKB (1) |
| Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation. DiMauro E.F., Newcomb J., Nunes J.J., Bemis J.E., Boucher C., Chai L., Chaffee S.C., Deak H.L., Epstein L.F., Faust T. et al. J. Med. Chem. 51:1681-1694(2008) · Mapped (1) |
| Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors. Hodous B.L., Geuns-Meyer S.D., Hughes P.E., Albrecht B.K., Bellon S., Caenepeel S., Cee V.J., Chaffee S.C., Emery M., Fretland J. et al. Bioorg. Med. Chem. Lett. 17:2886-2889(2007) · UniProtKB (1) |
| Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. Hodous B.L., Geuns-Meyer S.D., Hughes P.E., Albrecht B.K., Bellon S., Bready J., Caenepeel S., Cee V.J., Chaffee S.C., Coxon A. et al. J. Med. Chem. 50:611-626(2007) · UniProtKB (2) |